Stay updated on SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedA new revision entry 'Revision: v3.6.6' is added to the record history, representing the latest update to the study record's documentation. This updates the history log to reflect the most recent version.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision entry, v3.6.5, has been added to the study's record history. The prior revision entry, v3.6.4, has been removed from the list.SummaryDifference0.1%

- Check40 days agoChange DetectedA new revision entry (v3.6.4) was added to the study history, and the previous revision (v3.6.3) was removed, representing an update to the record version.SummaryDifference0.1%

- Check61 days agoChange DetectedA new revision entry, v3.6.3, is added to the study record history. The previous revision, v3.6.2, is removed from the history, updating the version trail for this record.SummaryDifference0.1%

- Check68 days agoChange DetectedThe revision history now shows a newer release (v3.6.2) and replaces the older v3.6.0 entry, reflecting a maintenance update to the page's versioning.SummaryDifference0.1%

- Check82 days agoChange DetectedThe study record history now shows new labels 'Last verified' and 'Last known status was' and adds a new revision entry 'Revision: v3.6.0'; the older labels 'Verified' and 'Last known status was:' plus the older 'Revision: v3.5.5' are removed from this view.SummaryDifference3%

Stay in the know with updates to SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page.